title: Diabetes mellitus after renal transplantation under FK 506 (tacrolimus) as primary immunosuppression.
authors.affiliation: Department of Urology and Surgery, Tokyo Women's Medical College, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Tanabe
authors.forename: S
authors.initials: S
authors.lastname: Koga
authors.forename: K
authors.initials: K
authors.lastname: Takahashi
authors.forename: K
authors.initials: K
authors.lastname: Sonda
authors.forename: T
authors.initials: T
authors.lastname: Tokumoto
authors.forename: T
authors.initials: T
authors.lastname: Babazono
authors.forename: T
authors.initials: T
authors.lastname: Yagisawa
authors.forename: H
authors.initials: H
authors.lastname: Toma
authors.forename: T
authors.initials: T
authors.lastname: Kawai
authors.forename: S
authors.initials: S
authors.lastname: Fuchinoue
authors.forename: S
authors.initials: S
authors.lastname: Teraoka
authors.forename: K
authors.initials: K
authors.lastname: Ota
mesh_terms: D000293:Adolescent; D000328:Adult; D003920:Diabetes Mellitus / Q000139:chemically induced / Q000453:epidemiology*; D003922:Diabetes Mellitus, Type 1 / Q000139:chemically induced / Q000453:epidemiology; D003924:Diabetes Mellitus, Type 2 / Q000139:chemically induced / Q000453:epidemiology; D005260:Female; D005500:Follow-Up Studies; D005951:Glucose Tolerance Test; D006650:Histocompatibility Testing; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D011183:Postoperative Complications; D012307:Risk Factors; D016559:Tacrolimus / Q000009:adverse effects*; D013997:Time Factors
chemical_list: D007166:Immunosuppressive Agents; D016559:Tacrolimus; D008775:Methylprednisolone